Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Institution
Articles 1 - 6 of 6
Full-Text Articles in Cardiology
Exome Sequence Association Study Of Levels And Longitudinal Change Of Cardiovascular Risk Factor Phenotypes In European Americans And African Americans From The Atherosclerosis Risk In Communities Study, Elena V Feofanova, Elise Lim, Han Chen, Minjae Lee, Ching-Ti Liu, L Adrienne Cupples, Eric Boerwinkle
Exome Sequence Association Study Of Levels And Longitudinal Change Of Cardiovascular Risk Factor Phenotypes In European Americans And African Americans From The Atherosclerosis Risk In Communities Study, Elena V Feofanova, Elise Lim, Han Chen, Minjae Lee, Ching-Ti Liu, L Adrienne Cupples, Eric Boerwinkle
Student and Faculty Publications
Cardiovascular disease (CVD) is responsible for 31% of all deaths worldwide. Among CVD risk factors are age, race, increased systolic blood pressure (BP), and dyslipidemia. Both BP and blood lipids levels change with age, with a dose-dependent relationship between the cumulative exposure to hyperlipidemia and the risk of CVD. We performed an exome sequence association study using longitudinal data with up to 7805 European Americans (EAs) and 3171 African Americans (AAs) from the Atherosclerosis Risk in Communities (ARIC) study. We assessed associations of common (minor allele frequency > 5%) nonsynonymous and splice-site variants and gene-based sets of rare variants with levels …
Cascade Screening And Treatment Initiation In Young Adults With Heterozygous Familial Hypercholesterolemia., Amy L. Peterson, Matthew Bang, Robert C. Block, Nathan D. Wong, Dean G. Karalis
Cascade Screening And Treatment Initiation In Young Adults With Heterozygous Familial Hypercholesterolemia., Amy L. Peterson, Matthew Bang, Robert C. Block, Nathan D. Wong, Dean G. Karalis
Division of Cardiology Faculty Papers
Heterozygous familial hypercholesterolemia (HeFH) creates elevated low-density lipoprotein cholesterol (LDL-C), causing premature atherosclerotic cardiovascular disease (ASCVD). Guidelines recommend cascade screening relatives and starting statin therapy at 8-10 years old, but adherence to these recommendations is low. Our purpose was to measure self-reported physician practices for cascade screening and treatment initiation for HeFH using a survey of 500 primary care physicians and 500 cardiologists: 54% "always" cascade screen relatives of an individual with FH, but 68% would screen individuals with "strong family history of high cholesterol or premature ASCVD", and 74% would screen a child of a patient with HeFH. The …
The Role Of Cardiovascular Ct In Occupational Health Assessment For Coronary Heart Disease: An Expert Consensus Document From The Society Of Cardiovascular Computed Tomography (Scct)., Ahmad M Slim, Emilio Fentanes, Michael K Cheezum Md, Iain T Parsons, Christopher Maroules, Billy Chen, Suhny Abbara, Kelley Branch, Prashant Nagpal, Nishant R Shah, Dustin M Thomas, Todd C Villines, Ron Blankstein, Leslee J Shaw, Matthew Budoff, Ed Nicol
The Role Of Cardiovascular Ct In Occupational Health Assessment For Coronary Heart Disease: An Expert Consensus Document From The Society Of Cardiovascular Computed Tomography (Scct)., Ahmad M Slim, Emilio Fentanes, Michael K Cheezum Md, Iain T Parsons, Christopher Maroules, Billy Chen, Suhny Abbara, Kelley Branch, Prashant Nagpal, Nishant R Shah, Dustin M Thomas, Todd C Villines, Ron Blankstein, Leslee J Shaw, Matthew Budoff, Ed Nicol
Parkview Heart Institute
No abstract provided.
Effects Of Endogenous Angiotensin Ii On Abdominal Aortic Aneurysms And Atherosclerosis In Angiotensin Ii-Infused Mice, Masayoshi Kukida, Hisashi Sawada, Satoko Ohno-Urabe, Deborah A. Howatt, Jessica J. Moorleghen, Marko Poglitsch, Alan Daugherty, Hong S. Lu
Effects Of Endogenous Angiotensin Ii On Abdominal Aortic Aneurysms And Atherosclerosis In Angiotensin Ii-Infused Mice, Masayoshi Kukida, Hisashi Sawada, Satoko Ohno-Urabe, Deborah A. Howatt, Jessica J. Moorleghen, Marko Poglitsch, Alan Daugherty, Hong S. Lu
Saha Cardiovascular Research Center Faculty Publications
No abstract provided.
Nanoanalytical Analysis Of Bisphosphonate-Driven Alterations Of Microcalcifications Using A 3d Hydrogel System And In Vivo Mouse Model, Jessica L. Ruiz, Joshua D. Hutcheson, Luis Cardoso, Amirala Bakhshian Nik, Alexandra Condado De Abreu, Tan Pham, Fabrizio Buffolo, Sara Busatto, Stefania Frederici, Andrea Ridolfi, Masanori Aikawa, Sergio Bertazzo, Paolo Bergese, Sheldon Weinbaum, Elena Aikawa
Nanoanalytical Analysis Of Bisphosphonate-Driven Alterations Of Microcalcifications Using A 3d Hydrogel System And In Vivo Mouse Model, Jessica L. Ruiz, Joshua D. Hutcheson, Luis Cardoso, Amirala Bakhshian Nik, Alexandra Condado De Abreu, Tan Pham, Fabrizio Buffolo, Sara Busatto, Stefania Frederici, Andrea Ridolfi, Masanori Aikawa, Sergio Bertazzo, Paolo Bergese, Sheldon Weinbaum, Elena Aikawa
Publications and Research
Vascular calcification predicts atherosclerotic plaque rupture and cardiovascular events. Retrospective studies of women taking bisphosphonates (BiPs), a proposed therapy for vascular calcification, showed that BiPs paradoxically increased morbidity in patients with prior acute cardiovascular events but decreased mortality in event-free patients. Calcifying extracellular vesicles (EVs), released by cells within atherosclerotic plaques, aggregate and nucleate calcification. We hypothesized that BiPs block EV aggregation and modify existing mineral growth, potentially altering microcalcification morphology and the risk of plaque rupture. Three-dimensional (3D) collagen hydrogels incubated with calcifying EVs were used to mimic fibrous cap calcification in vitro, while an ApoE−/− mouse was used …
Prevalence Of Cardiovascular Risk Factors In A Nationally Representative Adult Population With Inflammatory Bowel Disease Without Atherosclerotic Cardiovascular Disease, Tanushree Agrawal, Isaac Acquah, Amit K. Dey, Kerri Glassner, Bincy Abraham, Ron Blankstein, Salim S. Virani, Michael J. Blaha, Javier Valero-Elizondo, Nehal Mehta
Prevalence Of Cardiovascular Risk Factors In A Nationally Representative Adult Population With Inflammatory Bowel Disease Without Atherosclerotic Cardiovascular Disease, Tanushree Agrawal, Isaac Acquah, Amit K. Dey, Kerri Glassner, Bincy Abraham, Ron Blankstein, Salim S. Virani, Michael J. Blaha, Javier Valero-Elizondo, Nehal Mehta
Office of the Provost
Background and aims: Chronic inflammation is associated with premature atherosclerotic cardiovascular disease (ASCVD). We studied the prevalence of cardiovascular risk factors (CRFs) amongst individuals with IBD who have not developed ASCVD.
Methods: Our study population was derived from the 2015 - 2016 National Health Interview Survey. Those with ASCVD (defined as myocardial infarction, angina or stroke) were excluded. The prevalence of CRFs among individuals with IBD was compared with those without IBD. The odds CRFs among adults with IBD was assessed using logistic regression models.
Results: In our study population of 60,155 individuals, 786 (1.3%) had IBD. IBD was associated …